Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1
Titel:
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1
Auteur:
Montemurro, Filippo Ellis, Paul Anton, Antonio Wuerstlein, Rachel Delaloge, Suzette Bonneterre, Jacques Quenel-Tueux, Nathalie Linn, Sabine C. Irahara, Natsumi Donica, Margarita Lindegger, Nicolas Barrios, Carlos H.